Kevin J. Heyeck
Amministratore Delegato presso Chimeron Bio Corp.
Provenienza dei contatti di primo grado di Kevin J. Heyeck
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Chimeron Bio Corp.
Chimeron Bio Corp. Medical SpecialtiesHealth Technology Chimeron Bio Corp. is a biotechnology company based in the USA that is focused on developing a pipeline of products in oncology, rare genetic disorders, and infectious diseases using its proprietary chaesar™ platform. The American company is researching self-amplifying RNA (sRNA) to develop novel RNA drugs and vaccines for various diseases. Chimeron Bio is combining a first-in-class platform and the science of synthetic genomics to develop a robust portfolio of self-amplifying RNA therapeutics. The company was founded by Jolly Mazumdar, and the CEO is Kevin J. Heyeck.
4
| Holding Company | Medical Specialties | 4 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kevin J. Heyeck tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of California, Los Angeles | College/University | Undergraduate Degree | |
ABLYNX | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Navarra | College/University | Graduate Degree | |
Artá Capital SGEIC SA
Artá Capital SGEIC SA Investment ManagersFinance Artá Capital SGEIC SA (Artá Capital) is a private equity arm of Artá Partners SA founded in 2007. The firm is headquartered in Madrid, Spain. | Investment Managers | Consultant / Advisor | |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
BioAgilytix Labs LLC
BioAgilytix Labs LLC Miscellaneous Commercial ServicesCommercial Services BioAgilytix Labs LLC engages in the provision of specialized bioanalytical testing laboratory. It offers gene therapy, biosimilars, antibody drug conjugates and immuno-oncology solutions. The company was founded by Afshin Safavi in 2008 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Founder | |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Biotechnology | Chairman | |
BALX Holdings LLC
BALX Holdings LLC BiotechnologyHealth Technology BALX Holdings LLC operates as a biotechnology firm which offers health care services. The company was incorporated in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Dreamers Factory Innovacion Outpost SL
Dreamers Factory Innovacion Outpost SL Investment ManagersFinance Dreamers Factory Innovacion Outpost SL (Dreamers Factory) is a venture capital firm founded in 2019 by Jose Antonio Borge, Eneko Knörr and Gorka Fius. The firm is headquartered in Spain with an additional office in the US. | Investment Managers | Founder | |
Dreavent, Inc.
Dreavent, Inc. Investment ManagersFinance Dreavent, Inc (Dreavent) is a venture capital firm founded in 2020 by Gorka Fius and Leo Walter. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer | |
Safavi Applied Life Sciences LLC
Safavi Applied Life Sciences LLC BiotechnologyHealth Technology Safavi Applied Life Sciences LLC is a private company that provides versatile workspace shells for medical, dental, or therapy practices to customize their environment. The company is based in Englewood, CO and has subsidiaries in the United States. The company offers build-to-suit workspaces to help innovators start up faster. The company has over one million square feet of built-to-suit laboratories and workspaces for lease being planned and built along the I-25 corridor. The CEO of the company is Afshin Safavi. | Biotechnology | Chief Executive Officer | |
University of Kentucky College of Medicine | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Spagna | 4 |
Belgio | 3 |
Regno Unito | 2 |
Settori
Health Technology | 11 |
Consumer Services | 5 |
Finance | 4 |
Commercial Services | 2 |
Posizioni
Director/Board Member | 8 |
Chief Tech/Sci/R&D Officer | 5 |
Chief Executive Officer | 3 |
Founder | 3 |
Doctorate Degree | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Kevin J. Heyeck
- Connessioni Società